首页> 美国卫生研究院文献>Frontiers in Neurology >A Critical Review of Alberta Stroke Program Early CT Score for Evaluation of Acute Stroke Imaging
【2h】

A Critical Review of Alberta Stroke Program Early CT Score for Evaluation of Acute Stroke Imaging

机译:阿尔伯塔省卒中计划早期CT评分对急性卒中影像学评估的评论

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Assessment of ischemic stroke lesions on computed tomography (CT) or MRI using the Alberta Stroke Program Early CT Score (ASPECTS) is widely used to guide acute stroke treatment. We aimed to review the current evidence on ASPECTS. Originally, the score was developed for standardized lesion assessment on non-contrast CT (NCCT). Early studies described ASPECTS as a predictor of functional outcome and symptomatic intracranial hemorrhage after iv-thrombolysis with a threshold of ≤7 suggested to identify patients at high risk. Following studies rather pointed toward a linear relationship between ASPECTS and functional outcome. ASPECTS has also been applied to assess perfusion CT and diffusion-weighted MRI (DWI). Cerebral blood volume ASPECTS proved to be the best predictor of outcome, outperforming NCCT-ASPECTS in some studies. For DWI-ASPECTS varying thresholds to identify patients at risk for poor outcome were reported. ASPECTS has been used for patient selection in three of the five groundbreaking trials proving efficacy of mechanical thrombectomy published in 2015. ASPECTS values predict functional outcome after thrombectomy. Moreover, treatment effect of thrombectomy appears to depend on ASPECTS values being smaller or not present in low ASPECTS, while patients with ASPECTS 5–10 do clearly benefit from mechanical thrombectomy. However, as patients with low ASPECTS values were excluded from recent trials data on this subgroup is limited. There are several limitations to ASPECTS addressed in a growing number of studies. The score is limited to the anterior circulation, the template is unequally weighed and correlation with lesion volume depends on lesion location. Overall ASPECTS is a useful and easily applicable tool for assessment of prognosis in acute stroke treatment and to help guide acute treatment decisions regardless whether MRI or CT is used. Patients with low ASPECTS values are unlikely to achieve good outcome. However, methodological constraints of ASPECTS have to be considered, and based on present data, a clear cutoff value to define “low ASPECTS values” cannot be given.
机译:使用阿尔伯塔省卒中计划早期CT评分(ASPECTS)在计算机断层扫描(CT)或MRI上评估缺血性卒中病变已广泛用于指导急性卒中治疗。我们旨在审查有关ASPECTS的当前证据。最初,该分数是为在非对比CT(NCCT)上进行标准化病变评估而开发的。早期研究将ASPECTS描述为IV溶栓后功能预后和症状性颅内出血的预测指标,阈值≤7提示了高危患者的识别。随后的研究反而指出了ASPECTS与功能结果之间的线性关系。 ASPECTS也已用于评估灌注CT和弥散加权MRI(DWI)。在某些研究中,脑血容量ASPECTS被证明是预后的最佳预测指标,优于NCCT-ASPECTS。对于DWI-ASPECTS,报告了不同的阈值以识别有不良结果风险的患者。在2015年发表的五个证明机械性血栓切除术疗效的开创性试验中,有三个试验已将ASPECTS用于患者选择。ASPECTS值可预测血栓切除术后的功能结局。此外,血栓切除术的治疗效果似乎取决于ASPECTS值较小或在低ASPECTS中不存在,而ASPECTS 5-10的患者显然确实受益于机械血栓切除术。但是,由于ASPECTS值低的患者被排除在最近的试验之外,因此该亚组的数据有限。越来越多的研究解决了ASPECTS的一些局限性。评分仅限于前循环,模板的重量不均衡,与病变体积的相关性取决于病变部位。总体而言,ASPECTS是一种有用且易于应用的工具,可用于评估急性卒中治疗的预后并帮助指导急性治疗决策,无论是否使用MRI或CT。 ASPECTS值低的患者不太可能取得良好的疗效。但是,必须考虑ASPECTS的方法学约束,并且基于当前数据,不能给出定义“低ASPECTS值”的明确截止值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号